Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding—a multicenter analysis
European Radiology · 16.10.2024 · 35 (5) · 2746-2754
DOI: 10.1007/s00330-024-11102-x ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Radiology, online erschienen am 16.10.2024. Verfasst von Clarissa Hosse und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, 10117, Berli…. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Gastrointestinal Hemorrhage. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To assess the technical feasibility, safety, and clinical success rate of trans-arterial embolization (TAE) as an emergency treatment for acute lower gastrointestinal bleeding (LGIB). Materials and methods Consecutive patients who received urgent TAE due to active LGIB at five academic centers in Germany were retrospectively analyzed. LGIB was confirmed and localized using contrast-enhanced computed tomography (CT) or endoscopy. Outcome parameters including technical and clinical success rates as well as ischemia-related adverse events were analyzed. Furthermore, treatment-related variables that may affect technical and clinical success were analyzed using a regression model.
Results
One hundred and forty-one patients were included. TAE was performed in 91% (128/141) of patients. In 81% (114/141) of patients, TAE was performed due to active bleeding visible at angiography, the remaining 10% (14/141) underwent empiric embolization based on pre-interventional imaging. In 9% (13/141) of patients, no TAE was performed. Microcoils were the most used embolic 48.5% (62/128), followed by glue 23.5% (30/128) and Microparticles (8%; 10/128). In the case of bleeding visible in angiography, the technical success rate was 100% (114/114); the clinical success rate was 93.6% (120/128). Severe ischemia-related adverse events necessitating bowel surgery occurred in 14% (18/128) of all patients after embolization. Thirty-day mortality was 14% (21/141). Regression analysis revealed no significant correlations but a statistical trend toward a higher incidence of bowel resection when glue was used ( p = 0.090) and toward a higher 30-day mortality when an unselective embolization was performed ( p = 0.057).
Conclusion
TAE for LGIB has a high technical and clinical success rate. Severe ischemia-related adverse events necessitating bowel surgery occurred in 14% of patients without identifying a significant correlation to the embolization technique or an embolic. Key Points Question Is trans-arterial embolization (TAE) viable as an emergency treatment for acute lower gastrointestinal bleeding (LGIB)?
Findings
TAE demonstrated a 100% technical and 93.6% clinical success rate in treating acute LGIB, with severe ischemia-related adverse events occurring in 14% of patients. Clinical relevance TAE is highly effective and has an acceptable complication rate in treating lower gastrointestinal bleeding, emphasizing the need for a direct head-to-head comparison between endovascular and endoscopic therapy .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.
- Department of Diagnostic and Interventional Radiology, University Medical Center Mainz, Mainz, Germany.
- Institute of Diagnostic and Interventional Radiology, Hannover Medical School, 30625, Hannover, Germany.
- Institute of Interventional Radiology, University Hospital Schleswig-Holstein-Campus Lübeck, Lübeck, Germany.
- Institute of Diagnostic and Interventional Radiology and Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany.
- Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), 13353, Berlin, Germany.
Zitieren
APA
Hosse, C., Moos, M., Becker, L. S., Sieren, M., Müller, L., Stoehr, F., Schaarschmidt, B. M., Barbone, G., Collettini, F., Fehrenbach, U., Hinrichs, J. B., Kloeckner, R., Geisel, D., Tacke, F., Gebauer, B., & Auer, T. A. (2024). Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding—a multicenter analysis. European Radiology, 35(5), 2746-2754. https://doi.org/10.1007/s00330-024-11102-x
Vancouver
Hosse C, Moos M, Becker LS, Sieren M, Müller L, Stoehr F, et al. Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding—a multicenter analysis. European Radiology. 2024;35(5):2746-2754. doi:10.1007/s00330-024-11102-x
BibTeX
@article{Hosse2024,
author = {Hosse, Clarissa and Moos, Maximilian and Becker, Lena S and Sieren, Malte and Müller, Lukas and Stoehr, Fabian and Schaarschmidt, Benedikt M and Barbone, Gianluca and Collettini, Federico and Fehrenbach, Uli and Hinrichs, Jan B and Kloeckner, Roman and Geisel, Dominik and Tacke, Frank and Gebauer, Bernhard and Auer, Timo A},
title = {Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding—a multicenter analysis},
journal = {European Radiology},
year = {2024},
volume = {35},
number = {5},
pages = {2746--2754},
doi = {10.1007/s00330-024-11102-x}
}
EUVIMED